Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid versus ClinOleic in parenterally fed adult surgical ICU patients
2006-001080-38Phase 4Active
- Sponsor
- Klinikum Ludwigshafen
- Start
- Apr 2006
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of SMOFlipid and Clinoleic (2 arms), sponsored by Klinikum Ludwigshafen. Primary endpoint: Plasma leukotriene LTB5 concentration. Started Apr 2006; status: active.
02
Drugs
SMOFlipidClinoleic
Beyond the preview
Go deeper on 2006-001080-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001080-38.